These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 32065391)

  • 1. Neuromelanin Locus Coeruleus MRI Contrast in Migraine With Aura.
    Gollion C; Arribarat G; Ruidavets JB; Fabre N; Barège M; Bonneville F; Larrue V; Peran P
    Headache; 2020 Apr; 60(4):752-760. PubMed ID: 32065391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuromelanin-sensitive magnetic resonance imaging features of the substantia nigra and locus coeruleus in de novo Parkinson's disease and its phenotypes.
    Wang J; Li Y; Huang Z; Wan W; Zhang Y; Wang C; Cheng X; Ye F; Liu K; Fei G; Zeng M; Jin L
    Eur J Neurol; 2018 Jul; 25(7):949-e73. PubMed ID: 29520900
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reproducibility of locus coeruleus and substantia nigra imaging with neuromelanin sensitive MRI.
    Langley J; Huddleston DE; Liu CJ; Hu X
    MAGMA; 2017 Apr; 30(2):121-125. PubMed ID: 27687624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Substantia nigra neuromelanin magnetic resonance imaging in de novo Parkinson's disease patients.
    Reimão S; Pita Lobo P; Neutel D; Correia Guedes L; Coelho M; Rosa MM; Ferreira J; Abreu D; Gonçalves N; Morgado C; Nunes RG; Campos J; Ferreira JJ
    Eur J Neurol; 2015 Mar; 22(3):540-6. PubMed ID: 25534480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evidence for Locus Coeruleus-Norepinephrine System Abnormality in Military Posttraumatic Stress Disorder Revealed by Neuromelanin-Sensitive Magnetic Resonance Imaging.
    McCall A; Forouhandehpour R; Celebi S; Richard-Malenfant C; Hamati R; Guimond S; Tuominen L; Weinshenker D; Jaworska N; McQuaid RJ; Shlik J; Robillard R; Kaminsky Z; Cassidy CM
    Biol Psychiatry; 2024 Aug; 96(4):268-277. PubMed ID: 38296219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Optimizing neuromelanin contrast in the substantia nigra and locus coeruleus using a magnetization transfer contrast prepared 3D gradient recalled echo sequence.
    Liu Y; Li J; He N; Chen Y; Jin Z; Yan F; Haacke EM
    Neuroimage; 2020 Sep; 218():116935. PubMed ID: 32413460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuromelanin related ultra-high field signal intensity of the locus coeruleus differs between Parkinson's disease and controls.
    Wolters AF; Heijmans M; Priovoulos N; Jacobs HIL; Postma AA; Temel Y; Kuijf ML; Michielse S
    Neuroimage Clin; 2023; 39():103479. PubMed ID: 37494758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Age-related changes in locus ceruleus on neuromelanin magnetic resonance imaging at 3 Tesla.
    Shibata E; Sasaki M; Tohyama K; Kanbara Y; Otsuka K; Ehara S; Sakai A
    Magn Reson Med Sci; 2006 Dec; 5(4):197-200. PubMed ID: 17332710
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An investigation of neuromelanin distribution in substantia nigra and locus coeruleus in patients with Parkinson's disease using neuromelanin-sensitive MRI.
    Liu Q; Wang P; Liu C; Xue F; Wang Q; Chen Y; Hou R; Chen T
    BMC Neurol; 2023 Aug; 23(1):301. PubMed ID: 37580712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Locus Coeruleus and Substantia Nigra Pathology With Cognitive and Motor Functions in Patients With Parkinson Disease.
    Prasuhn J; Prasuhn M; Fellbrich A; Strautz R; Lemmer F; Dreischmeier S; Kasten M; Münte TF; Hanssen H; Heldmann M; Brüggemann N
    Neurology; 2021 Sep; 97(10):e1007-e1016. PubMed ID: 34187859
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unraveling the contributions to the neuromelanin-MRI contrast.
    Priovoulos N; van Boxel SCJ; Jacobs HIL; Poser BA; Uludag K; Verhey FRJ; Ivanov D
    Brain Struct Funct; 2020 Dec; 225(9):2757-2774. PubMed ID: 33090274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histologic validation of locus coeruleus MRI contrast in post-mortem tissue.
    Keren NI; Taheri S; Vazey EM; Morgan PS; Granholm AC; Aston-Jones GS; Eckert MA
    Neuroimage; 2015 Jun; 113():235-45. PubMed ID: 25791783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mild cognitive impairment in de novo Parkinson's disease: A neuromelanin MRI study in locus coeruleus.
    Li Y; Wang C; Wang J; Zhou Y; Ye F; Zhang Y; Cheng X; Huang Z; Liu K; Fei G; Zhong C; Zeng M; Jin L
    Mov Disord; 2019 Jun; 34(6):884-892. PubMed ID: 30938892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative magnetization transfer imaging of the human locus coeruleus.
    Trujillo P; Petersen KJ; Cronin MJ; Lin YC; Kang H; Donahue MJ; Smith SA; Claassen DO
    Neuroimage; 2019 Oct; 200():191-198. PubMed ID: 31233908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regional locus coeruleus degeneration is uncoupled from noradrenergic terminal loss in Parkinson's disease.
    Doppler CEJ; Kinnerup MB; Brune C; Farrher E; Betts M; Fedorova TD; Schaldemose JL; Knudsen K; Ismail R; Seger AD; Hansen AK; Stær K; Fink GR; Brooks DJ; Nahimi A; Borghammer P; Sommerauer M
    Brain; 2021 Oct; 144(9):2732-2744. PubMed ID: 34196700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A distinct neuromelanin magnetic resonance imaging pattern in parkinsonian multiple system atrophy.
    Simões RM; Castro Caldas A; Grilo J; Correia D; Guerreiro C; Pita Lobo P; Valadas A; Fabbri M; Correia Guedes L; Coelho M; Rosa MM; Ferreira JJ; Reimão S
    BMC Neurol; 2020 Nov; 20(1):432. PubMed ID: 33243166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Higher locus coeruleus MRI contrast is associated with lower parasympathetic influence over heart rate variability.
    Mather M; Joo Yoo H; Clewett DV; Lee TH; Greening SG; Ponzio A; Min J; Thayer JF
    Neuroimage; 2017 Apr; 150():329-335. PubMed ID: 28215623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuromelanin-sensitive magnetic resonance imaging in the study of mental disorder: A systematic review.
    Lv Q; Wang X; Lin P; Wang X
    Psychiatry Res Neuroimaging; 2024 Apr; 339():111785. PubMed ID: 38325165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuromelanin in parkinsonian disorders: an update.
    Martin-Bastida A; Pietracupa S; Piccini P
    Int J Neurosci; 2017 Dec; 127(12):1116-1123. PubMed ID: 28460588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of neuromelanin-sensitive MRI to distinguish schizophrenic and depressive patients and healthy individuals based on signal alterations in the substantia nigra and locus ceruleus.
    Shibata E; Sasaki M; Tohyama K; Otsuka K; Endoh J; Terayama Y; Sakai A
    Biol Psychiatry; 2008 Sep; 64(5):401-6. PubMed ID: 18452894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.